The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

According to a recent report by CIDRAP and the CDC, published on November 24, 2025, viral activity is on the rise, and it's ...

Respiratory virus season is upon the United States as the cold weather months set in, meaning cases of COVID-19, influenza and RSV are set to increase. In its annual outlook report, the Centers for ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

For people whose autumn agenda includes getting vaccinated against respiratory diseases — COVID-19, flu, and, for some, RSV — this year may be surprisingly routine. Following several confusing months ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

Vaccines for pregnant women will be targeted for extra scrutiny by the vaccine safety advisory panel to the Centers for ...

The CDC's vaccine advisory committee is set to meet Thursday and Friday to discuss the childhood vaccine schedule, adjuvants ...